Correlation of the LumiraDx SARS-CoV-2 antibody Test to other SARS-CoV-2 antibody tests and to viral neutralization

13 Oct 2022

In this poster, LumiraDX shows the interpretative correlation of the rapid, point-of-care LumiraDx SARS-CoV-2 Antibody Test to the Mt. Sinai Hospital COVID-19 ELISA IgG Antibody Test and to viral neutralization.

SARS-CoV-2 Ab Test

LumiraDx

The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.

(0)

Links

Tags